SPI Healthcare
3.597,97
PKT
+5,14
PKT
+0,14
%
Werbung
Leider sind zu diesem Wert keine aktuellen Kursdaten verfügbar, die Stammdaten finden Sie im unteren Seitenbereich.
Analysen zu SPI Healthcare-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 12.11.09 | Novartis kaufen | Raiffeisen Centrobank AG | |
| 22.10.09 | Novartis buy | Société Générale Group S.A. (SG) | |
| 22.10.09 | Novartis kaufen | Hamburger Sparkasse AG (Haspa) | |
| 22.10.09 | Novartis akkumulieren | Independent Research GmbH | |
| 22.10.09 | Novartis outperform | Cazenove Group Limited | |
| 21.10.09 | Novartis equal-weight | Morgan Stanley | |
| 14.10.09 | Novartis buy | Helvea | |
| 12.10.09 | Novartis outperform | Cowen and Company, LLC | |
| 12.10.09 | Novartis outperform | Cowen and Company, LLC | |
| 09.10.09 | Novartis buy | Citigroup Corp. | |
| 07.10.09 | Novartis kaufen | SEB AG | |
| 30.09.09 | Novartis buy | Citigroup Corp. | |
| 30.09.09 | Novartis buy | Société Générale Group S.A. (SG) | |
| 24.09.09 | Novartis | Focus Money | |
| 15.09.09 | Novartis buy | Jefferies & Company Inc. | |
| 10.09.09 | Novartis outperform | Exane-BNP Paribas SA | |
| 09.09.09 | Novartis overweight | JP Morgan Chase & Co. | |
| 08.09.09 | Novartis buy | Goldman Sachs Group Inc. | |
| 08.09.09 | Novartis buy | Nomura | |
| 03.09.09 | Novartis akkumulieren | Independent Research GmbH | |
| 02.09.09 | Novartis | Zürcher Kantonalbank AG | |
| 02.09.09 | Novartis kaufen | Raiffeisen Centrobank AG | |
| 27.08.09 | Novartis | Focus Money | |
| 24.08.09 | Novartis buy | UBS AG | |
| 03.08.09 | Novartis | Wirtschaftswoche | |
| 29.07.09 | Novartis kaufen | Hamburger Sparkasse AG (Haspa) | |
| 21.07.09 | Novartis buy | SEB AG | |
| 20.07.09 | Novartis buy | Société Générale Group S.A. (SG) | |
| 20.07.09 | Novartis kaufen | Euro am Sonntag | |
| 17.07.09 | Novartis kaufen | Independent Research GmbH | |
| 20.07.09 | Novartis outperform | Sanford C. Bernstein and Co., Inc. | |
| 17.07.09 | Novartis hold | Citigroup Corp. | |
| 20.07.09 | Novartis outperform | Credit Suisse Group | |
| 17.07.09 | Novartis overweight | JP Morgan Chase & Co. | |
| 16.07.09 | Novartis buy | Société Générale Group S.A. (SG) | |
| 15.07.09 | Novartis neutral | Credit Suisse Group | |
| 13.07.09 | Novartis buy | Société Générale Group S.A. (SG) | |
| 06.07.09 | Novartis kaufen | Independent Research GmbH | |
| 30.06.09 | Novartis outperform | Exane-BNP Paribas SA | |
| 17.06.09 | Novartis | DaxVestor |